Oxomollugin, a potential inhibitor of lipopolysaccharide-induced nitric oxide production including nuclear factor kappa B signals

J Nat Med. 2015 Oct;69(4):608-11. doi: 10.1007/s11418-015-0927-3. Epub 2015 Jul 1.

Abstract

Mollugin, a naphthoquinone derivative, was reported to possess various biological activities such as anti-inflammatory and anti-tumor activity. Mollugin isolated from Rubia tinctorum roots inhibited lipopolysaccharide-induced nitric oxide (NO) production in RAW264.7 macrophages. However, mollugin synthesized for further investigation of its anti-inflammatory mechanism showed weak activity in addition to unstable assay results. From the result of analysis on a degradation product of mollugin, oxomollugin was found to be the main active substance of mollugin degradation, showing a potent inhibitory activity on NO-production including nuclear factor kappa B signals.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Anti-Inflammatory Agents / pharmacology*
  • Benzopyrans / chemistry*
  • Benzopyrans / pharmacology*
  • Cell Line
  • Lipopolysaccharides / antagonists & inhibitors*
  • Lipopolysaccharides / pharmacology
  • Macrophages / drug effects*
  • Macrophages / metabolism
  • Mice
  • NF-kappa B / metabolism*
  • Nitric Oxide / antagonists & inhibitors*
  • Nitric Oxide / biosynthesis*
  • Nitric Oxide / metabolism
  • Pyrans
  • Signal Transduction / drug effects

Substances

  • Anti-Inflammatory Agents
  • Benzopyrans
  • Lipopolysaccharides
  • NF-kappa B
  • Pyrans
  • oxomollugin
  • Nitric Oxide
  • rubimaillin